Aggressive investor
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Dow getting hit hard, $DVAX higher
Thanks. Good post. digging
$DVAX Year end result out. Cahs in hand 122 million and everything on track ...
http://www.nasdaq.com/press-release/dynavax-reports-fourth-quarter-and-year-end-2014-financial-results-20150305-00127
Oversight board recommends continuing Heplisav-B Phase 3 trial
http://seekingalpha.com/news/2340156-oversight-board-recommends-continuing-heplisav-b-phase-3-trial
$DVAX short squeeze on Thursday and Friday
The margin call wave will hit like massive thunderstorm
Keep watching
$DVAX current price just an appetizer. Risk has been dramatically reduced and we will now see more institutional and hedge fund players hesitant build on their current holdings. At present institutional holding close to 80%. O/S 26 million, Market Cap 535 million. Expected Market cap to be before approval over 2 billion
The independent Data and Safety Monitoring Board (DSMB) recommended twice to go ahead with ongoing phase 3 study of HEPLISAV-B(TM). Source: Press release.
This will drive prices much higher! Short term (30-45 days), we may see hitting $30. Watch what happens as each passing month goes buy with no new information from Dynavax. The lack of information is a huge positive as it means that the trial is progressing along just fine as far as safety is concerned.
Phase 3 to release October, 2015
As always do your own DD
GLTA
$DVAX current price just an appetizer. Risk has been dramatically reduced and we will now see more institutional and hedge fund players hesitant build on their current holdings. At present institutional holding close to 80%. O/S 26 million, Market Cap 535 million. Expected Market cap to be before approval over 2 billion
The independent Data and Safety Monitoring Board (DSMB) recommended twice to go ahead with ongoing phase 3 study of HEPLISAV-B(TM). Source: Press release.
This will drive prices much higher! Short term (30-45 days), we may see hitting $30. Watch what happens as each passing month goes buy with no new information from Dynavax. The lack of information is a huge positive as it means that the trial is progressing along just fine as far as safety is concerned.
Phase 3 to release October, 2015
GLTA
$DVAX- Dynavax Technologies Corporation Price Target Update
http://wallstreetpulse.org/dynavax-technologies-corporation-price-target-update-2/339058/
$DVAX: MLV Reiterates Upbeat View Of Dynavax Technologies Following DSMB’s 2nd Recommendation
http://www.smarteranalyst.com/2015/03/03/mlv-reiterates-upbeat-view-dynavax-technologies-following-dsmbs-2nd-recommendation/
$DVAX: MLV Reiterates Upbeat View Of Dynavax Technologies Following DSMB’s 2nd Recommendation
http://www.smarteranalyst.com/2015/03/03/mlv-reiterates-upbeat-view-dynavax-technologies-following-dsmbs-2nd-recommendation/
$DVAX Update: Dynavax announces second recommendation to continue Helpisav-B Phase 3 study
http://wallstreetpulse.org/dynavax-technologies-corporation-nasdaqdvax-update-dynavax-announces-second-recommendation-to-continue-helpisav-b-phase-3-study/338498/
Dynavax Technologies Corporation (NASDAQ:DVAX) Update: Dynavax announces second recommendation to continue Helpisav-B Phase 3 study
http://wallstreetpulse.org/dynavax-technologies-corporation-nasdaqdvax-update-dynavax-announces-second-recommendation-to-continue-helpisav-b-phase-3-study/338498/
See you at $60
$IGXT (2) Two more drugs to be filed this year, PAR VersaFilm, DAVA VersaTab
IntelGenx will have (4) drug products in FDA review this year with (2) two
of them nearing the end of there cycles and hopefully adding to the revenue
stream in the near future.
Partner PAR Pharma VersaFilm Suboxone
Partner Redhill VersaFilm RIZAPORT
Partner Dava VersaTab Hypertension
Partner PAR VersaFilm (undisclosed)
RIZAPORT Europe decision in Q2, 2015
Behind these FDA filed products IntelGenx
currently has (5) other drug development products
active in there pilot studies. (3) three of the drugs
are partnered and (2) two of the drugs un-partnered.
And of course, we all know the status of our Forfivo XL
product. Q4 April, 2015
http://www.intelgenx.com/investors/presentations.html
$IGXT (2) Two more drugs to be filed this year, PAR VersaFilm, DAVA VersaTab
IntelGenx will have (4) drug products in FDA review this year with (2) two
of them nearing the end of there cycles and hopefully adding to the revenue
stream in the near future.
Partner PAR Pharma VersaFilm Suboxone
Partner Redhill VersaFilm RIZAPORT
Partner Dava VersaTab Hypertension
Partner PAR VersaFilm (undisclosed)
Behind these FDA filed products IntelGenx
currently has (5) other drug development products
active in there pilot studies. (3) three of the drugs
are partnered and (2) two of the drugs un-partnered.
And of course, we all know the status of our Forfivo XL
product. Q4 April, 2015
http://www.intelgenx.com/investors/presentations.html
Update: Dynavax Technologies Corporation Short Interest Grows by 6.7%
http://candlestrips.com/update-dynavax-technologies-corporation-short-interest-grows-by-6-7/340217/
Update: Dynavax Technologies Corporation Short Interest Grows by 6.7%
http://candlestrips.com/update-dynavax-technologies-corporation-short-interest-grows-by-6-7/340217/
Biotech Data in March, 2015
$BIIB '037
$BDSI P3
$CNAT NASH
$CTIC P3
$DPRX P3
$GNFT NASH
$HRTX P3
$MEIP MDS
$NKTR P3
$OCUL P3
$SRNE BE
$VRTX '661
It is not where a stock has been, it is where it is going. IGXT IS GOING!
$IGXT broke resistance level..old highs ahead
IGXT looking good. Golden Cross. technical heaven.
IGXT looking good
Keep an eye on IGXT
Swing BIOC
Good move..
San Francisco Becomes The First City to Ban Sale of Plastic Bottles
http://globalflare.com/san-francisco-becomes-the-first-city-to-ban-sale-of-plastic-bottles/
$IGXT Low float 57M !! This thing can fly to a new orbit very quickly !!!
$IGXT Low float 57M !! This thing can fly to a new orbit very quickly !!!
$IGXT upside-surprise news flash away from $1.50
$IGXT upside-surprise news flash away from $1.50
MEI Pharma Inc(NASDAQ:MEIP) - go baby go
almost 300% in the money
Greed is good.
LONG LIVE BIOTECH VALUES BOARD!!!
Full-body transplants will be possible within two years, says controversial surgeon Sergio Canavero
http://www.independent.co.uk/news/science/fullbody-transplants-will-be-possible-within-two-years-says-controversial-surgeon-sergio-canavero-10071112.html?utm_source=indynewsletter&utm_medium=email26022015
IntelGenx Technologies Finally Come Around ...
http://www.smallcapnetwork.com/IntelGenx-Technologies-and-Zogenix-Finally-Come-Around-ZGNX-IGXT/s/via/10/article/view/p/mid/2/id/205/
IntelGenx Technologies Finally Come Around ...
http://www.smallcapnetwork.com/IntelGenx-Technologies-and-Zogenix-Finally-Come-Around-ZGNX-IGXT/s/via/10/article/view/p/mid/2/id/205/
$IGXT gross sales of Forfivo XL® totaled $8.9M in the year ending December 31st, 2014, an increase of 230% vs. $2.7M in the preceding year.
$IGXT gross sales of Forfivo XL® totaled $8.9M in the year ending December 31st, 2014, an increase of 230% vs. $2.7M in the preceding year.
means...
you are screwed and potential bag-holders
SPPI Spectrum Tanks On Fusilev Court Ruling
DewDiligence - with due respect, pls allow me post this small cap
IntelGenx Provides Update on Sales of Forfivo XL(R)
http://finance.yahoo.com/news/intelgenx-provides-sales-forfivo-xl-130200875.html
IntelGenx Provides Update on Sales of Forfivo XL(R)
http://web.tmxmoney.com/article.php?newsid=73646932&qm_symbol=IGX